Skip to main content
. 2016 Mar 8;7(15):20945–20952. doi: 10.18632/oncotarget.7976

Figure 2. Kaplan-Meyer survival curve for recurrence-free survival.

Figure 2

A. and overall survival B. in NSCLC patients after surgery for Tenascin-C low- and high-level group.